Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Whole exome sequencing of low grade serous ovarian carcinoma identifies genomic events associated with clinical outcome.
Gynecol Oncol. 2023 Jul;174:157-166. doi: 10.1016/j.ygyno.2023.04.011. Epub 2023 May 17.
Gynecol Oncol. 2023.
PMID: 37207500
Free article.
Distinct histopathological features are associated with molecular subtypes and outcome in low grade serous ovarian carcinoma.
Hollis RL, Thomson JP, van Baal J, Ilenkovan N, Churchman M, van de Vijver K, Dijk F, Meynert AM, Bartos C, Rye T, Croy I, Diana P, van Gent M, Creedon H, Nirsimloo R, Lok C, Gourley C, Herrington CS.
Hollis RL, et al. Among authors: nirsimloo r.
Sci Rep. 2023 May 11;13(1):7681. doi: 10.1038/s41598-023-34627-5.
Sci Rep. 2023.
PMID: 37169775
Free PMC article.
Item in Clipboard
Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma.
Hollis RL, Stillie LJ, Hopkins S, Bartos C, Churchman M, Rye T, Nussey F, Fegan S, Nirsimloo R, Inman GJ, Herrington CS, Gourley C.
Hollis RL, et al. Among authors: nirsimloo r.
Cancers (Basel). 2021 Nov 21;13(22):5839. doi: 10.3390/cancers13225839.
Cancers (Basel). 2021.
PMID: 34830992
Free PMC article.
Item in Clipboard
The safety and efficacy of olaparib therapy in patients with relapsed ovarian cancer.
Nirsimloo R, Gourley C.
Nirsimloo R, et al.
Expert Rev Anticancer Ther. 2016 Jun;16(6):597-603. doi: 10.1080/14737140.2016.1182429.
Expert Rev Anticancer Ther. 2016.
PMID: 27115428
Review.
Item in Clipboard
Cite
Cite